哮喘表型:持续哮喘中咳嗽与喘息能否预测急性加重?
研究基于1701例未控制哮喘患者每日两次电子记录的症状数据,分析咳嗽与喘息的昼夜特征及其与治疗反应和急性加重的关系。多数患者咳嗽与喘息高度相关(r=0.73),但可区分咳嗽为主和喘息为主两种表型;症状与急性加重频率关联不佳,MART较沙丁胺醇减少约三分之一急性加重,且在症状最少的患者中效果最明显。
要点
- 未控制哮喘中咳嗽与喘息高度相关(r=0.73),但存在以咳嗽为主和以喘息为主的不同表型。
- 症状频率与急性加重频率关联不佳,提示可能存在不同的病理生理机制。
- MART较沙丁胺醇减少约三分之一急性加重,症状最少的患者获益最大。
核心结论
- 未控制哮喘中咳嗽与喘息高度相关但可区分不同表型,症状与急性加重关联不佳,MART在症状较少者中减少急性加重更明显。
研究设计与样本
- 分析1701例未控制哮喘患者每日两次电子记录的症状数据,比较沙丁胺醇缓解治疗与超细倍氯米松/福莫特罗维持加缓解治疗(MART)。
主要发现
- 症状在年龄较大和体质指数较高的患者中更常见。
- 多数患者咳嗽与喘息密切相关(r=0.73)。
- 识别出咳嗽为主和喘息为主两种表型,前者多为超重年长女性,后者多为年长男性。
- 两种治疗对咳嗽和喘息昼夜症状的减轻程度相似。
- MART较沙丁胺醇减少约三分之一急性加重频率,在症状最少的患者中效果最大。
关键数值与推荐
- 咳嗽与喘息相关系数r=0.73。
- MART较沙丁胺醇减少约三分之一急性加重频率。
临床怎么用
- 对症状较少的未控制哮喘患者,MART可能作为优先选择以减少急性加重。
- 临床应关注咳嗽为主与喘息为主的不同表型,而非仅凭症状频率评估急性加重风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Little is known of the long-term symptom profile in uncontrolled asthma and whether symptoms can predict distinct phenotypes. The primary objective of these analyses was to assess diurnal profile of cough and wheeze in an uncontrolled asthma population. Secondary outcomes were to examine how these symptom profiles influence response to treatment.Twice-daily electronically recorded data from 1701 patients were examined in relation to the population demographics. Reliever treatment with salbutamol was then compared with extra-fine beclometasone/formoterol maintenance and reliever therapy (MART). Exacerbation frequency was then correlated with the symptom profile.Symptoms were commoner in older patients with an increased body mass index. In most patients, reported cough and wheeze were closely correlated (r=0.73). Two phenotypes of cough- and wheeze-predominant patients were identified; the former were overweight, older females and the latter older males. Diurnal symptoms of cough and wheeze were similarly attenuated by both therapies. MART reduced exacerbation frequency by a third compared with salbutamol, and this effect was greatest in patients with fewest reported symptoms.While cough and wheeze are highly correlated in uncontrolled asthma, some patients predominantly have cough whereas others wheeze. Symptoms and exacerbation frequency appear poorly associated, suggesting an alternative pathophysiology. MART may be the preferred option in those with fewest symptoms.
引用
- Morjaria JB, Rigby AS, Morice AH, et al. Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma? Eur Respir J. 2017. PMID: 29217600. doi:10.1183/13993003.01366-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。